Christopher S Lee1, Jill M Gelow, Christopher V Chien, Shirin O Hiatt, Julie T Bidwell, Quin E Denfeld, Kathleen L Grady, James O Mudd. 1. Christopher S. Lee, PhD, RN, FAHA, FAAN, FHFSA Carol A. Lindeman Distinguished Professor, School of Nursing and Knight Cardiovascular Institute, Oregon Health & Science University, Portland. Jill M. Gelow, MD, MPH Assistant Professor, Knight Cardiovascular Institute, Oregon Health & Science University, Portland. Christopher V. Chien, MD Assistant Professor, REX Healthcare, University of North Carolina, Raleigh. Shirin O. Hiatt, MPH, MS, RN Project Coordinator, School of Nursing, Oregon Health & Science University, Portland. Julie T. Bidwell, PhD, RN Post-doctoral Fellow, Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia. Quin E. Denfeld, PhD, RN Post-doctoral Fellow, Knight Cardiovascular Institute, Oregon Health & Science University, Portland. Kathleen L. Grady, PhD, RN, FAHA, FAAN, FHFSA Professor, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. James O. Mudd, MD Associate Professor, Knight Cardiovascular Institute, Oregon Health & Science University, Portland.
Abstract
BACKGROUND: Although we know that the quality of life generally improves after left ventricular assist device (LVAD) implantation, we know little about how symptoms change in response to LVAD. METHODS: The purpose of this study was to compare the changes in symptoms between bridge and destination therapy patients as part of a prospective cohort study. Physical (dyspnea and wake disturbances) and affective symptoms (depression and anxiety) were measured before LVAD and at 1, 3, and 6 months after LVAD. Multiphase growth modeling was used to capture the 2 major phases of change: initial improvements between preimplant and 1 month after LVAD and subsequent improvements between 1 and 6 months after LVAD. RESULTS: The sample included 64 bridge and 22 destination therapy patients as the preimplant strategy. Destination patients had worse preimplant dyspnea and wake disturbances, and they experienced greater initial improvements in these symptoms compared with bridge patients (all P < .05); subsequent change in both symptoms were similar between groups (both P > .05). Destination patients had worse preimplant depression (P = .042) but experienced similar initial and subsequent improvements in depression in response to LVAD compared with bridge patients (both P > .05). Destination patients had similar preimplant anxiety (P = .279) but experienced less initial and greater subsequent improvements in anxiety after LVAD compared with bridge patients (both P < .05). CONCLUSION: There are many differences in the magnitude and timing of change in symptom responses to LVAD between bridge and destination therapy patients. Detailed information on changes in specific symptoms may better inform shared decision-making regarding LVAD.
BACKGROUND: Although we know that the quality of life generally improves after left ventricular assist device (LVAD) implantation, we know little about how symptoms change in response to LVAD. METHODS: The purpose of this study was to compare the changes in symptoms between bridge and destination therapy patients as part of a prospective cohort study. Physical (dyspnea and wake disturbances) and affective symptoms (depression and anxiety) were measured before LVAD and at 1, 3, and 6 months after LVAD. Multiphase growth modeling was used to capture the 2 major phases of change: initial improvements between preimplant and 1 month after LVAD and subsequent improvements between 1 and 6 months after LVAD. RESULTS: The sample included 64 bridge and 22 destination therapy patients as the preimplant strategy. Destination patients had worse preimplant dyspnea and wake disturbances, and they experienced greater initial improvements in these symptoms compared with bridge patients (all P < .05); subsequent change in both symptoms were similar between groups (both P > .05). Destination patients had worse preimplant depression (P = .042) but experienced similar initial and subsequent improvements in depression in response to LVAD compared with bridge patients (both P > .05). Destination patients had similar preimplant anxiety (P = .279) but experienced less initial and greater subsequent improvements in anxiety after LVAD compared with bridge patients (both P < .05). CONCLUSION: There are many differences in the magnitude and timing of change in symptom responses to LVAD between bridge and destination therapy patients. Detailed information on changes in specific symptoms may better inform shared decision-making regarding LVAD.
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2012-10 Impact factor: 10.247
Authors: Barbara Riegel; Sarah J Ratcliffe; William S Weintraub; Steven L Sayers; Lee R Goldberg; Sheryl Potashnik; Terri E Weaver; Susan J Pressler Journal: Eur J Heart Fail Date: 2012-04-17 Impact factor: 15.534
Authors: Kathleen L Grady; David C Naftel; Susan Myers; Mary Amanda Dew; Gerdi Weidner; John A Spertus; Katharine Idrissi; Hochang B Lee; Edwin C McGee; James K Kirklin Journal: J Heart Lung Transplant Date: 2014-10-31 Impact factor: 10.247
Authors: Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Kiswendsida Sawadogo; Jérôme Ambroise; Steven Vercauteren; Marc Castadot; Michel Vanhalewyn; Jacques Col; Annie Robert Journal: Qual Life Res Date: 2015-10-11 Impact factor: 4.147
Authors: Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Christopher V Chien; Jessica Harman Thompson; Jill M Gelow; Kathleen L Grady; Christopher S Lee Journal: Eur J Cardiovasc Nurs Date: 2022-10-14 Impact factor: 3.593
Authors: Quin E Denfeld; Kenneth M Faulkner; Mary Roberts Davis; Beth A Habecker; Christopher V Chien; Jill M Gelow; James O Mudd; Shirin O Hiatt; Kathleen L Grady; Christopher S Lee Journal: Eur J Cardiovasc Nurs Date: 2021-10-27 Impact factor: 3.593
Authors: Jonathan J Edwards; Jonathan B Edelson; Hannah Katcoff; Antara Mondal; Debra Lefkowitz; Nosheen Reza; Thomas C Hanff; Heather Griffis; Jeremy A Mazurek; Joyce Wald; Anjali T Owens; Carol A Wittlieb-Weber; Danielle S Burstein; Pavan Atluri; Matthew J O'Connor; Lee R Goldberg; Payman Zamani; Peter W Groeneveld; Joseph W Rossano; Kimberly Y Lin; Edo Y Birati Journal: Am Heart J Date: 2021-06-03 Impact factor: 5.099
Authors: Crispino Tosto; Luigi Adamo; Heidi Craddock; Maria Di Blasi; Rosario Girgenti; Francesco Clemenza; Robert M Carney; Gregory Ewald Journal: Sci Rep Date: 2019-07-25 Impact factor: 4.379
Authors: Kevin Willy; Christian Ellermann; Florian Reinke; Benjamin Rath; Julian Wolfes; Lars Eckardt; Florian Doldi; Felix K Wegner; Julia Köbe; Nexhmedin Morina Journal: J Cardiovasc Dev Dis Date: 2022-08-10